ATPC (Agape ATP Corp.) Earnings growth in current year

ATPC (Agape ATP Corporation) - company brandmark

Agape ATP Corporation (ATPC) is scaling its network of longevity centers across Asia. The year-over-year EPS percentage deviation on the GURU.Markets chart illustrates the current trend, where the value 0.00 represents the current metric. Revenue is driven by the sale of dietary supplements and cosmetics, although geopolitical conflicts create risks for raw material supplies and patent protection in foreign markets.

ATPC: agapeatpgroup.com Earnings per share growth in current year 02/21/2024 - 11/16/2026

Financial and market metric breakdowns for Agape ATP Corporation (ATPC)

- share price and expert price forecast:
- business market valuation indicators:
Basic company analysis:ATPC - agapeatpgroup.com
Finished products of Agape ATP Corp.

This indicator measures the annual change in earnings per share, reflecting the growth rate of real shareholder income. Positive momentum confirms business efficiency, while a decline signals stagnation. By analyzing current year-over-year EPS trends, investors assess the speed of the market reaction to financial reports. For Agape ATP Corporation (ATPC), this metric is critical due to high competition in the dietary supplement sector, as marketing expenses and discounts directly pressure bottom-line profits.

Main competitors

ASND: Net earnings per one share growth for the current year|MDGL (Madrigal Corp) - Earnings growth in current year|Earnings growth in current year Corcept Therapeutics|Earnings growth in current year RYTM|Earnings per share growth in current year AKRO (Akero Therapeutics, Inc.)|Earnings per share growth in current year metsera.com MTSR|MoonLake Corp (MLTX) - Earnings per share growth rate in current year|CRNX - Earnings per share growth in current year|NAMS: Earnings per share growth in current year|SLNO: Earnings growth in current year|FOLD - Expected net earnings per share growth this year|Earnings per share growth in current year 89bio Pharma|Agios Corp (AGIO) - Expected net earnings per share growth this year|Earnings per share growth in current year structuretx.com (GPCR)|Net earnings per share growth this year mimedx.com MDXG|Earnings per share growth in current year Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Earnings per share growth in current year|MBX: Net earnings per share growth this year|Altimmune Corp - Net earnings per one share growth for the current year|Aardvark Therapeutics Inc (AARD) - Earnings per share growth in current year|Net earnings per share change in current year Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Earnings growth in current year|Net earnings per share growth this year Biomea Fusion (BMEA)|Earnings growth in current year QNCX|Net earnings per one share growth for the current year GUTS|Earnings growth in current year VTVT (vTv Therapeutics Inc.)|Earnings per share increase in current year PLUR|Synlogic Inc. - Earnings growth in current year|LPCN (Lipocine) - Earnings per share growth this year|MTNB (Matinas BioPharma Holdings Inc.) - Net earnings per share growth this year|SPRB (Spruce Biosciences, Inc.) - Earnings per share growth in current year|GLTO (galecto.com) - Earnings growth in current year|Net earnings per share growth this year carmellrx.com (CTCX)|Earnings per share growth in current year Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Earnings per share increase in current year|radiuspharm.com - Net earnings per share growth this year